We are delighted to announce that Polyphotonix, based at NETPark, Sedgefield, has been selected as a finalist in the pitching competition.
BioCap is the only specialist life science investment and showcase conference in the North of England. Now in it’s seventh year the BioCap Conference provides a unique meeting place connecting investors, companies who are seeking finance and those who have a track record of raising finance.
The pitching competition is aimed at established life science business seeking or shortly starting to seek funding of £500k or above, the competition provides companies with an exciting opportunity to present to a panel of investors and delegates at the BioCap conference.
The competition kindly sponsored by Catapult Ventures once again proved to be hugely popular this year and the judging committee were impressed with the number and quality of the applications received.
We are delighted to announce this years finalists who now have the opportunity to give their pitches to the BioCap conference on 27th September at the Alderley Park Conference Centre (see http://www.bionow.co.uk/events/2018biocapconference.aspx).
The 2018 BioCap Pitching Competition Finalists are:
The conference is a catalyst in helping business to realise their full potential whatever your funding requirements are.
This year, investors from some of the leading life science investment organisations include:
Bamburgh Capital, Calculus Capital, YFM, IP Group, North West Business Angels, WGN, Innovate UK, Apposite Capital, Arix Bioscience, Deepbridge Capital, Dynasty Bio, Mercia Fund Managers, Epidarex Capital, Equity Gap, EV Group, GHO Capital Partners, GSK, Bioscience Managers, Kreos Capital, Angels in Medcity, London Stock Exchange, Midven, LifeArc, MTI Ventures, N+1 Singer, New Wave Ventures, Northland Capital Partners, NorthStar Ventures, Parkwalk Advisors, Peel Hunt, Ruffena Capital, Scottish Development International, Silicon Valley Bank, Spark Impact, SV Life Sciences, Syndicate Room, Steris, Torreya, Up, WG Partners, Acceleris Capital, Alderley Park Ventures, Catapult Ventures, Mercia Technologies, Longwall Ventures, Dementia Discovery Fund, Pfizer LLC.
To view the full conference programme and to register for the conference please click HERE.